Miller Howard Investments Inc Ironwood Pharmaceuticals Inc Transaction History

Miller Howard Investments Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$10.1 - $11.6 $1,706 - $1,960	169 Added 0.57%	30,023 $319,000
Q1 2023 May 03, 2023	BUY	$10.37 - $12.56 $404 - $489	39 Added 0.13%	29,854 $314,000
Q4 2022 Feb 02, 2023	BUY	$9.9 - $12.43 $63,577 - $79,825	6,422 Added 27.45%	29,815 $369,000
Q3 2022 Oct 27, 2022	BUY	$10.14 - $12.38 $557 - $680	55 Added 0.24%	23,393 $242,000
Q2 2022 Jul 26, 2022	BUY	$11.05 - $12.72 $257,884 - $296,859	23,338 New	23,338 $269,000

235

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $568M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Miller Howard Investments Inc with notifications on news.